Nasdaq’s Sonnet to Merge With Rorschach, Form $888 Million Crypto Treasury Firm

Source of this Article
The Defiant 3 months ago 243

Sonnet BioTherapeutics, a Nasdaq-listed clinical-stage biotechnology company, said it will merge with Rorschach I LLC in an all-stock deal that values the combined business at about $888 million



Facebook X WhatsApp LinkedIn Pinterest Telegram Print Icon


BitRss shares this Content always with Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License.

Read Entire Article


Screenshot generated in real time with SneakPeek Suite

BitRss World Crypto News | Market BitRss | Short Urls
Design By New Web | ScriptNet